Literature DB >> 18668831

The role of bile salts in diarrhoea of patients with ulcerative colitis.

T A Miettinen.   

Abstract

Faecal bile salt elimination, which was determined in patients with ulcerative colitis, was mostly within normal limits, suggesting that in this disease water and electrolyte diarrhoea was hardly contributed to by excessive amounts of bile salts in the large bowel. In a therapeutic trial cholestyramine had no beneficial effect on the general condition, diarrhoea, or faecal composition, findings which further strengthen the view that bile salts play no role in the diarrhoea of ulcerative colitis, provided that the disease is limited to the large bowel. Faecal elimination of cholesterol as bile salts and neutral steroids tended initially to be higher than normal, but increased less than in controls during treatment with cholestyramine, particularly in the heavier patients. Serum cholesterol was low in the patients with ulcerative colitis and decreased by cholestyramine less (27%) than in controls (39%).

Entities:  

Year:  1971        PMID: 18668831      PMCID: PMC1411760          DOI: 10.1136/gut.12.8.632

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

2.  A simplified method for the determination of chromic oxide (Cr2 O3) when used as an index substance.

Authors:  D W BOLIN; R P KING; E W KLOSTERMAN
Journal:  Science       Date:  1952-12-05       Impact factor: 47.728

3.  [On the absorption inhibiting effect of bile acids].

Authors:  W Forth; W Rummel; H Glasner
Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol       Date:  1966

4.  Lignin: a bile-salt sequestrating agent.

Authors:  M A Eastwood; R H Girdwood
Journal:  Lancet       Date:  1968-11-30       Impact factor: 79.321

Review 5.  Ulcerative colitis.

Authors:  R Wright
Journal:  Gastroenterology       Date:  1970-06       Impact factor: 22.682

6.  Fecal steroid excretion during weight reduction in obese patients with hyperlipidemia.

Authors:  T A Miettinen
Journal:  Clin Chim Acta       Date:  1968-02       Impact factor: 3.786

7.  [Management of chologenic diarrhea and steatorrhea in the enteral bile acid losing syndrome using cholestyramine and medium-chain triglycerides].

Authors:  K Sickinger
Journal:  Dtsch Med Wochenschr       Date:  1969-05-30       Impact factor: 0.628

8.  Control of tenesmus and diarrhea by cholestyramine administration.

Authors:  G G Rowe
Journal:  Gastroenterology       Date:  1967-12       Impact factor: 22.682

9.  Dietary beta-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies.

Authors:  S M Grundy; E H Ahrens; G Salen
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

10.  Bile salt malabsorption in regional ileitis, ileal resection and mannitol-induced diarrhea.

Authors:  W E Meihoff; F Kern
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

View more
  13 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

Authors:  R G Shorter; D A Shephard
Journal:  Am J Dig Dis       Date:  1975-07

Review 2.  GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation.

Authors:  T Lieu; G Jayaweera; N W Bunnett
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  Diarrhoea: mechanisms and treatment.

Authors:  T S Low-Beer; A E Read
Journal:  Gut       Date:  1971-12       Impact factor: 23.059

4.  Ten Reasons to Think about Bile Acids in Managing Inflammatory Bowel Disease.

Authors:  Michael Camilleri
Journal:  J Crohns Colitis       Date:  2020-08-31       Impact factor: 9.071

5.  Characterization of the ascending colon fluids in ulcerative colitis.

Authors:  Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer B Dressman; Androniki Poulou; Christos Reppas
Journal:  Pharm Res       Date:  2010-04-29       Impact factor: 4.200

6.  Double-blind trial of cholestyramine in post-vagotomy diarrhoea.

Authors:  V M Duncombe; T D Bolin; A E Davis
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

7.  High concentration and retained amidation of fecal bile acids in patients with active ulcerative colitis.

Authors:  N Tanida; Y Hikasa; M Dodo; K Sawada; A Kawaura; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1986-06

8.  The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice.

Authors:  Farzad Alemi; Daniel P Poole; Jonathan Chiu; Kristina Schoonjans; Fiore Cattaruzza; John R Grider; Nigel W Bunnett; Carlos U Corvera
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

9.  Faecal bile acid concentration of patients with carcinoma or increased risk of carcinoma in the large bowel.

Authors:  D G Mudd; S T McKelvey; W Norwood; D T Elmore; A D Roy
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

10.  Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis.

Authors:  R Schilli; R I Breuer; F Klein; K Dunn; A Gnaedinger; J Bernstein; M Paige; M Kaufman
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.